{
  "Variants Include": [
    {
      "Gene": "PARK2",
      "variants": [
        {
          "HGVS": "NM_001130005.1:c.1052G>A",
          "cDNA Change": {
            "transcript": "NM_001130005.1",
            "ref": "G",
            "alt": "A",
            "position": "1052"
          },
          "Protein Change": {
            "ref": "C",
            "alt": "Y",
            "position": "351"
          },
          "Description in input context": "C.1052G>A (p.C351Y)"
        },
        {
          "HGVS": "NM_001130005.1:c.1052G>T",
          "cDNA Change": {
            "transcript": "NM_001130005.1",
            "ref": "G",
            "alt": "T",
            "position": "1052"
          },
          "Protein Change": {
            "ref": "C",
            "alt": "S",
            "position": "351"
          },
          "Description in input context": "C.1052G>T (p.C351S)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Autosomal Recessive Parkinsonism 12",
    "MONDO": "MONDO:0011771"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with wild-type and mutant PARK2 constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130005.1:c.1052G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Mutant parkin (p.C351Y) showed 60% reduced protein expression compared to wild-type."
        },
        {
          "Variant": "NM_001130005.1:c.1052G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Mutant parkin (p.C351S) exhibited 55% reduced protein stability."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 construct was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection served as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used to compare group means."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression â‰¥ 80% of wild-type levels",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression < 60% of wild-type levels",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Luciferase Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were co-transfected with reporter plasmids and PARK2 constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130005.1:c.1052G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "p.C351Y mutant showed 30% increased transcriptional activity compared to wild-type."
        },
        {
          "Variant": "NM_001130005.1:c.1052G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "p.C351S mutant exhibited 25% increased transcriptional activity."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type PARK2 construct was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection served as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "t-test was used to compare mutant vs. wild-type groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Transcriptional activity within 10% of wild-type levels",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Transcriptional activity > 20% deviation from wild-type",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Patient-derived material",
        "Material Name": "Postmortem brain tissue",
        "Description": "Brain tissue from patients with PARK2 mutations was analyzed for parkin localization."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001130005.1:c.1052G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "altered subcellular localization",
          "Result Description": "p.C351Y mutant showed cytoplasmic accumulation of parkin instead of mitochondrial localization."
        },
        {
          "Variant": "NM_001130005.1:c.1052G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "altered subcellular localization",
          "Result Description": "p.C351S mutant exhibited reduced mitochondrial localization and increased cytoplasmic retention."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five patient samples with the same mutation were analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "No technical replicates were explicitly mentioned."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Control brain tissue from healthy donors was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "No staining was performed without primary antibody."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Qualitative analysis based on immunostaining intensity and localization patterns."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Uniform mitochondrial localization in >90% of cells",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cytoplasmic accumulation in >50% of cells",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}